GIORGI, MARIO
 Distribuzione geografica
Continente #
NA - Nord America 25.486
AS - Asia 13.043
EU - Europa 10.310
SA - Sud America 2.783
OC - Oceania 407
AF - Africa 355
Continente sconosciuto - Info sul continente non disponibili 17
Totale 52.401
Nazione #
US - Stati Uniti d'America 24.284
SG - Singapore 3.647
CN - Cina 3.516
IT - Italia 2.820
HK - Hong Kong 2.713
BR - Brasile 2.082
GB - Regno Unito 1.113
PL - Polonia 1.009
SE - Svezia 986
BG - Bulgaria 935
CA - Canada 884
VN - Vietnam 779
DE - Germania 688
TR - Turchia 645
RU - Federazione Russa 533
UA - Ucraina 416
IN - India 414
FI - Finlandia 407
AU - Australia 345
KR - Corea 323
CL - Cile 241
CH - Svizzera 236
MX - Messico 217
NL - Olanda 196
FR - Francia 191
ES - Italia 166
JP - Giappone 153
AR - Argentina 142
BD - Bangladesh 127
ID - Indonesia 126
CO - Colombia 96
AT - Austria 90
IR - Iran 89
IE - Irlanda 82
EC - Ecuador 77
EG - Egitto 74
GR - Grecia 74
PT - Portogallo 74
ZA - Sudafrica 71
IQ - Iraq 70
BE - Belgio 64
TH - Thailandia 63
NZ - Nuova Zelanda 62
PK - Pakistan 61
TW - Taiwan 57
PE - Perù 51
VE - Venezuela 45
CI - Costa d'Avorio 44
RO - Romania 43
CZ - Repubblica Ceca 31
DK - Danimarca 31
SA - Arabia Saudita 30
SN - Senegal 29
JO - Giordania 28
UZ - Uzbekistan 28
MA - Marocco 26
MY - Malesia 26
CR - Costa Rica 23
IL - Israele 21
KE - Kenya 19
NP - Nepal 19
DZ - Algeria 18
HU - Ungheria 18
LV - Lettonia 18
UY - Uruguay 18
NG - Nigeria 17
PH - Filippine 17
PY - Paraguay 17
AE - Emirati Arabi Uniti 15
TN - Tunisia 15
JM - Giamaica 14
NO - Norvegia 14
KH - Cambogia 13
KZ - Kazakistan 13
PA - Panama 13
BO - Bolivia 12
EU - Europa 12
LT - Lituania 12
BJ - Benin 10
ET - Etiopia 10
RS - Serbia 10
AZ - Azerbaigian 9
SK - Slovacchia (Repubblica Slovacca) 8
BB - Barbados 7
BY - Bielorussia 7
DO - Repubblica Dominicana 7
GT - Guatemala 7
HR - Croazia 7
OM - Oman 7
TT - Trinidad e Tobago 7
BN - Brunei Darussalam 6
EE - Estonia 6
KG - Kirghizistan 6
LY - Libia 6
MT - Malta 6
AL - Albania 5
ZW - Zimbabwe 5
BH - Bahrain 4
GL - Groenlandia 4
HN - Honduras 4
Totale 52.336
Città #
Woodbridge 3.020
Hong Kong 2.681
Ashburn 2.155
Ann Arbor 1.963
Singapore 1.862
Houston 1.806
Fairfield 1.736
Chandler 1.355
Santa Clara 984
Milan 937
Sofia 932
Dallas 926
Beijing 832
Seattle 736
Shanghai 730
Wilmington 702
New York 634
Cambridge 621
Jacksonville 596
Ottawa 584
Serra 468
Princeton 467
Boardman 425
Lawrence 379
Izmir 354
Medford 333
Nanjing 333
Hefei 326
Redwood City 264
Seoul 252
Los Angeles 247
Des Moines 204
Bern 182
San Jose 179
Istanbul 173
São Paulo 167
Dearborn 141
Redondo Beach 141
Buffalo 140
Rome 137
Dong Ket 134
Ho Chi Minh City 123
Santiago 123
Nanchang 120
Menlo Park 114
Jüchen 108
San Diego 108
Council Bluffs 102
London 101
Munich 88
Tokyo 83
Shenyang 82
Boulder 81
Falls Church 81
Hanoi 79
Columbus 78
Sydney 76
Montréal 71
The Dalles 70
Rio de Janeiro 66
Vienna 66
Hebei 64
Kunming 64
Frankfurt am Main 61
Guangzhou 59
Ogden 59
Khulna 58
Bogotá 57
Changsha 57
Ames 55
Tianjin 53
Pune 52
Curitiba 49
Manchester 49
Norwalk 44
Abidjan 43
Jiaxing 43
Mumbai 43
Brisbane 42
Pisa 42
Fuzhou 41
Hangzhou 41
Belo Horizonte 40
Mcallen 40
Melbourne 40
Cairo 39
Jakarta 38
Brasília 36
Mexico City 36
Montreal 36
Helsinki 35
Utrecht 35
Amsterdam 34
Canberra 34
Porto Alegre 34
Athens 33
Birmingham 33
Bristol 33
Lima 33
Washington 33
Totale 34.776
Nome #
Trazodone: A review of its pharmacological properties and its off-label use in dogs and cats 3.483
Paracetamol: A Focus on Dogs 1.159
DEVELOPMENT AND VALIDATION OF A NEW HPLC-FLUORIMETRIC METHOD TO DETERMINE EPIRUBICIN AND ITS METABOLITEEPIRUBICINOL IN DOG PLASMA 1.026
ANTINOCICEPTIVE PROPERTIES OF HYDRO ALCOHOLIC EXTRACTS OF ANETHUM GRAVEOLENS L. (DILL) SEED AND AERIAL PARTS IN MICE 417
BIOPHARMACEUTICS OF METOCLOPRAMIDE: INTRAVENOUS, INTRAMUSCULAR, SUBCUTANEOUS AND PER RECTUM ADMINISTRATIONS IN RABBITS 387
CJ-023,423 (Grapiprant) a potential novel active compound with antihyperalgetic properties for veterinary patients 314
A BRIEF OVERVIEW OF THE COXIB DRUGS IN THE VETERINARY FIELD 281
Novel LC-MS/MS method for CJ-023423 (Grapiprant) determination in rabbit plasma 262
Pilot in vivo investigation of cerium oxide nanoparticles as a novel anti-obesity pharmaceutical formulation 257
EVALUATION OF PLASMA DETECTABLE CONCENTRATIONS OF TWO LIDOCAINE TRANSDERMAL FORMULATIONS AND THEIR ANALGESIC EFFECT IN THE HORSE 230
MIRTAZAPINE IN BEAGLE DOGS 224
Analytical Method Validation of Vilazodone with Spectrofluorimetric Detection in Rabbit Plasma 224
Clinical, pharmacodynamic and pharmacokinetic results of a prospective phase II study on oral metronomic vinorelbine and dexamethasone in castration-resistant prostate cancer patients 219
First-line metronomic chemotherapy in a metastatic model of spontaneous canine tumours: a pilot study 215
Anticonvulsant activity of hydroalcoholic phoenix dactylifera fruit extract and pimpinella anisum oil in mice 213
A NEW HPLC METHOD FOR THALIDOMIDE DETECTION IN HUMAN PLASMA 211
Nutlin-loaded magnetic solid lipid nanoparticles for targeted glioblastoma treatment 208
USE OF A LASERCYTE® FOR THE COMPLETE BLOOD COUNT IN DOGS WITH ONCOHEMATOLOGICAL DISORDERS 206
PHARMACOKINETIC/PHARMACODYNAMIC ASSESSMENTS OF 10 MG/KG TRAMADOL INTRAMUSCULAR INJECTION IN YELLOW-BELLIED SLIDER TURTLES (TRACHEMYS SCRIPTA SCRIPTA). 205
Natural substances as new potential strategies for the treatment of Leishmaniosisin Dogs 200
Bioanalytical Method Validation and Quantification of Flupirtine in Canine Plasma by HPLC with Spectrofluorimetric Detection 200
Pharmacokinetic and pharmacodynamic evaluations of levofloxacin in broiler chickens 191
DEVELOPMENT AND VALIDATION OF A NEW GC-MS METHOD FOR DETECTION OF TRAMADOL, O-DESMETHYLTRAMADOL, 6-ACETYLMORPHINE AND MORPHINE IN BLOOD, BRAIN, LIVER, AND KIDNEY OF WISTAR RATS TREATED WITH THE COMBINATION OF HEROIN AND TRAMADOL 190
PILOT IN VIVO TOXICOLOGICAL INVESTIGATION OF BORON NITRIDE NANOTUBES 190
DEVELOPMENT AND VALIDATION OF A NEW GC-MS METHOD FOR DETECTION OF TRAMADOL, O-DESMETHYLTRAMADOL, 6-ACETYLMORPHINE AND MORPHINE IN BLOOD, BRAIN, LIVER, AND KIDNEY OF WISTAR RATS TREATED WITH THE COMBINATION OF HEROIN AND TRAMADOL 188
INULIN BASED HYDROGEL FOR ORAL DELIVERY OF FLUTAMIDE: PREPARATION, CHARACTERIZATION AND IN VIVO RELEASE STUDIES 183
Pharmacokinetics of Sulpiride Following Intravenous, Intramuscular and Oral Single Dose Administration in Nurse Mares 181
NEW HPLC METHOD TO DETECT INDIVIDUAL OPIOIDS (HEROIN AND TRAMADOL) AND THEIR METABOLITES IN THE BLOOD OF RATS ON COMBINATION TREATMENT 178
PHARMACOKINETICS OF METHYLPHENIDATE AFTER ORAL ADMINISTRATION OF IMMEDIATE AND SUSTAINED RELEASE PREPARATIONS IN BEAGLE DOGS 176
Pharmacokinetic/pharmacodynamic evaluation of grapiprant in a carrageenan-induced inflammatory pain model in the rabbit 175
Effects of liquid and freeze-dried grapefruit juice on the pharmacokinetics of praziquantel and its metabolite 4′-hydroxy praziquantel in beagle dogs 173
PHARMACOKINETICS AND PHARMACODYNAMICS OF ZOLPIDEM AFTER ORAL ADMINISTRATION OF A SINGLE DOSE IN DOGS 173
COMPARISON OF INJECTABLE PARECOXIB VERSUS ROBENACOXIB FOR PERI-OPERATIVE USE IN DOGS: PRELIMINARY RESULTS 173
ABNORMAL FINDINGS IN HAEMOGRAMS OF DACHSHUND PUPPIES: PRESUMPTIVE (IMMUNODEFICIENCY) FAMILIAL DISEASE 172
BIOCOMPATIBILITY OF BORON NITRIDE NANOTUBES: AN UP-DATE OF IN VIVO TOXICOLOGICAL INVESTIGATION 172
Validation of an HPLC-FL method for the determination of tepoxalin and its major metabolite in horse plasma 170
Dispositions of enrofloxacin and its major metabolite ciprofloxacin in Thai swamp buffaloes 169
Pharmacokinetics of Metoclopramide After IntraARTERIAL, Intramuscular, Subcutaneous, and Perrectal Administration in Rabbits 168
Pharmacokinetics of Bedrocan®, a cannabis oil extract, in fasting and fed dogs: An explorative study 168
Gabapentin in Cattle: A Pharmacology Snapshot 166
CLINICAL INTERACTION BETWEEN GRAPEFRUIT-JUICE AND CYCLOSPORINE: IS THERE ANY INTEREST FOR VETERINARY MEDICINE? 165
Pharmacokinetics of meloxicam in lactating goats (Capra hircus) and its quantification in milk after a single intravenous and intramuscular injection 165
QUANTIFICATION OF TAPENTADOL IN CANINE PLASMA BY HPLC WITH SPECTROFLUORIMETRIC DETECTION: DEVELOPMENT AND VALIDATION OF A NEW METHODOLOGY 165
PHARMACOKINETICS OF METHYLPHENIDATE FOLLOWING TWO ORAL FORMULATIONS (IMMEDIATE AND SUSTAINED RELEASE) IN THE DOG 164
A BRIEF OVERVIEW OF OUR CURRENT UNDERSTANDING OF NIVALENOL: A GROWING POTENTIAL DANGER YET TO BE FULLY INVESTIGATED 164
PHARMACOKINETCIS STUDY OF CLAZURIL (APPERTEX®) IN EGGS AND PLASMA FROM LAYING HENS AFTER SINGLE AND MULTIPLE TREATMENT BY A NEW HPLC METHOD 163
Simultaneous detection and quantification of parecoxib and valdecoxib in canine plasma by HPLC with spectrofluorimetric detection: development and validation of a new methodology. 163
PHARMACOKINETIC INVESTIGATIONS OF THE MARKER ACTIVE METABOLITE-4-METHYLAMINO-ANTIPYRIN AFTER INTRAVENOUS AND INTRAMUSCULAR INJECTION OF METAMIZOLE IN HEALTHY SHEEP 163
Pharmacokinetic and pharmacodynamic evaluations of a 10 mg/kg enrofloxacin intramuscular administration in bearded dragons (Pogona vitticeps): A preliminary assessment 161
ANIMAL POISONING FREQUENCY IN CENTRAL ITALY (YEARS 2003-2004) 160
EVALUATION OF TRAMADOL AND ITS MAIN METABOLITES IN HORSES PLASMA BY HPLC-FL AND LC-ESI-MS/MS TECHNIQUES 160
PHARMACOKINETICS OF MIRTAZAPINE AND ITS MAIN METABOLITES AFTER SINGLE INTRAVENOUS AND ORAL ADMINISTRATIONS IN RATS AT TWO DOSE RATES 160
PHARMACOKINETIC PROFILES OF THE NOVEL COX-2 SELECTIVE INHIBITOR CIMICOXIB IN DOGS 159
LABORATORY DIAGNOSTIC EXAMINATIONS IN VETERINARY TOXICOLOGY 159
Analgesici oppiodi: HPLC-FL e LC-UV-ESI-MS/MS per la determinazione simultanea del tramadolo e dei suoi metaboliti nel plasma di cavallo 158
BIOGENIC AMINE CONTENT IN “PECORINO DEL PARCO DI MIGLIARINO - SAN ROSSORE” 158
DETECTION AND QUANTIFICATION OF CIMICOXIB, A NOVEL COX-2 INHIBITOR, IN CANINE PLASMA BY HPLC WITH SPECTROFLUORIMETRIC DETECTION: DEVELOPMENT AND VALIDATION OF A NEW METHODOLOGY 158
Cardiovascular effects and intraoperative pharmacokinetics of tramadol in sheep undergoing spinal surgery 158
PHARMACOKINETICS OF INTRAVENOUS AND INTRAMUSCULAR PARECOXIB IN HEALTHY BEAGLES 157
ORAL ADMINISTRATION OF TEPOXALIN IN THE HORSE: A PK/PD STUDY 157
Ex vivo antibacterial activity of levofloxacin against Escherichia coli and its pharmacokinetic profile following intravenous and oral administrations in broilers 157
Pharmacokinetics and disposition of flupirtine in the horse 156
Pharmacokinetics of levosulpiride after single-dose administration by different routes in sheep (Ovis aries Linnaeus) 156
A comparative kinetic study of thiamphenicol in pre-ruminant lambs and calves 155
DETECTION AND QUANTIFICATION OF THE SELECTIVE EP4 RECEPTOR ANTAGONIST CJ-023423 (GRAPIPRANT) IN CANINE PLASMA BY HPLC WITH SPECTROFLUORIMETRIC DETECTION 155
Pharmacokinetics and estimated bioavailability of grapiprant, a novel selective prostaglandin E2 receptor antagonist, after oral administration in fasted and fed dogs 155
Cebranopadol, a novel first-in-class drug candidate: Method validation and first exploratory pharmacokinetic study in rabbits 155
BLOOD CONCENTRATION OF ENROFLOXACIN AND ITS METABOLITE CIPROFLOXACIN IN YELLOW-BELLIED SLIDER TURTLES (TRACHEMYS SCRIPTA SCRIPTA), AFTER A SINGLE INTRACOELOMIC INJECTION OF ENROFLOXACIN 154
MIRTAZAPINE IN VETERINARY MEDICINE A PHARMACOLOGICAL RATIONALE FOR ITS APPLICATION IN CHRONIC PAIN 153
HIGH PERFORMANCE LIQUID CHROMATOGRAPHIC DETERMINATION OF THALIDOMIDE IN PATIENTS AFFECTED BY HEPATOCELLULAR CARCINOMA 153
A NEW HIGH-PERFORMANCE LIQUID CHROMATOGRAPHIC METHOD FOR THE DETERMINATION OF IOHEXOL AND p-AMINOHIPPURIC ACID IN PLASMA OF DOGS 152
PHARMACOKINETIC OF TRAMADOL AND ITS MAJOR CONJUGATES AFTER SINGLE PER OS ADMINISTRATION OF THE SUSTAINED TABLET AND PER RECTUM SUPPOSITORIES FORMULATIONS IN DOGS 152
Effects of liquid and freeze-dried grapefruit juice on the pharmacokinetics of praziquantel and its metabolite 4 '-hydroxy praziquantel in beagle dogs 152
Role of Natural Products in Ameliorating Drugs and Chemicals Toxicity 152
Pharmacokinetic Assessment of the Marker Active Metabolites 4-Methyl-amino-antipyrine and 4-Acetyl-amino-antipyrine After Intravenous and Intramuscular Injection of Metamizole (Dipyrone) in Healthy Donkeys 152
A new HPLC method to determine glomerular filtration rate and effective renal plasma flow in conscious dogs by single intravenous administration of iohexol and p-aminohippuric acid 151
Determination of tramadol and metabolites by HPLC-FL and HPLC-MS/MS in urine of dogs 151
GLI ANALGESICI IN MEDICINA VETERINARIA. Animali da compagnia (oppioidi, a2 agonisti e ketamina) 149
PHARMACOKINETICS OF THE NOVEL ATYPICAL OPIOID TAPENTADOL FOLLOWING ORAL AND INTRAVENOUS ADMINISTRATION IN DOGS 149
PHARMACOKINETIC EVALUATION OF TRAMADOL AND ITS MAJOR METABOLITES AFTER SINGLE ORAL SUSTAINED TABLET ADMINISTRATION IN THE DOG: A PILOT STUDY 149
Apoptosis and gene expression in Jurkat human T cells and lymphoid tissues of fusarenon-X-treated mice 149
Pharmacokinetics of levosulpiride after single-dose administration in goats (Capra hircus) by different routes of administration 149
Pharmacokinetics of Bedrocan (marijuana extract oil) in fasted and fed dogs: a pilot study 149
PHARMACOKINETICS OF MIRTAZAPINE AND ITS MAIN METABOLITES AFTER SINGLE ORAL ADMINISTRATION IN FASTING/FED HORSES 148
CHARACTERIZATION OF IN VIVO PLASMA METABOLITES OF TEPOXALIN IN HORSES USING LC-MS-MS 148
The role of clomipramine in potentiating the teratogenic effects of caffeine in pregnant rats: a histopathological study 148
THE PHARMACOKINETICS AND IN VITRO/EX VIVO CYCLOOXYGENASE SELECTIVITY OF PARECOXIB AND ITS ACTIVE METABOLITE VALDECOXIB IN CATS 148
PHARMACOKINETIC PROFILES OF THE ANALGESIC DRUG FLUPIRTINE IN CATS 148
IN SITU FORMING GEL LIKE DEPOT OF A POLYASPARTAMIDE-POLYLACTIDE COPOLYMER FOR ONCE A WEEK ADMINISTRATION OF SULPIRIDE 148
hCG is more effective than the GnRH agonist buserelin for inducing the first ovulation of the breeding season in mares 148
CONSTRUCTION AND EVALUATION OF SPONGE SCAFFOLDS FROM HYALURONIC ACID DERIVATIVES FOR POTENTIAL CARTILAGE REGENERATION 147
Clinical studies of metronomic chemotherapy in dogs 147
Pharmacokinetics of marbofloxacin in freshwater crocodiles (Crocodylus siamensis) after intravenous and intramuscular administration 147
Toxicokinetics and tissue distribution of nivalenol in broiler chickens 147
ASSESSMENT OF THE PHARMACOKINETIC PROFILE OF TRAMADOL AND ITS MAIN METABOLITES IN PLASMA AND URINE FORM DOGS ORALLY ADMINISTERED WITH CONTRAMAL®, WITH OR WITHOUT FREEZE-DRIED GRAPE-FRUIT JUICE 146
PHARMACOKINETIC STUDY OF DICLAZURIL IN PRE-RUMINANT AND RUMINANT LAMBS 146
Pharmacokinetic and urine profile of tramadol and its major metabolites following oral immediate release capsules administration in dogs 144
TREATMENT OF CANINE LYMPHOMA AS A MODEL FOR HUMANS 144
CLINICAL AND HEMATOLOGICAL ADVERSE EFFECTS AFTER ADMINISTRATION OF TWO DIFFERENT CHEMOTHERAPY PROTOCOLS IN DOGS AFFECTED BY LYMPHOMA 144
IN VITRO METABOLISM OF TRAMADOL IN HORSES: PRELIMINARY DATA 142
Totale 22.709
Categoria #
all - tutte 140.323
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 140.323


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.066 0 0 0 0 0 0 187 330 400 283 264 602
2021/20224.397 149 304 155 303 720 604 134 251 215 160 268 1.134
2022/20233.898 548 364 298 385 513 565 88 295 564 34 188 56
2023/20246.088 622 547 526 402 668 782 218 328 136 1.089 309 461
2024/202511.967 135 546 186 644 871 972 1.012 900 1.434 1.832 1.361 2.074
2025/20267.511 678 1.580 1.488 1.228 1.028 1.321 188 0 0 0 0 0
Totale 53.378